Relations between the macrophage electrophoretic mobility test and the rhodanide level in patients with malignant tumors, autoaggression diseases and after transplantation
Jülich, W.D.; Weuffen, W.; Jenssen, H.L.; Köhler, H.
Acta Biologica et Medica Germanica 34(9): 1541-1547
1975
ISSN/ISBN: 0001-5318 PMID: 769454 Document Number: 84209
In patients with malignant tumors, autoaggression diseases and following transplantations the blood rhodanide level was found to increase; a correlation with the results of the MEM test was established.
Document emailed within 1 workday
Related Documents
Yongde, S.; Zhensheng, T.; Chuanshen, L.; Baoguo, X.; Zijun, L.; Yifei, S.; Yanfang, J.; Xindi, Y.; Meizhen, L.; Xuezhen, S. 1979: Macrophage electrophoretic mobility test for brain tumors and malignancies Chinese Medical Journal 92(3): 211-215Malkovský, M.; Bubeník, J.; Holán, V.; Hasek, M. 1979: Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity Folia Biologica 25(3): 179-187
Shenton, B.R. 1978: Applications of the macrophage electrophoretic mobility test (M.E.M.) Bollettino dell'Istituto Sieroterapico Milanese 56(6): 557-564
Metzner, G.; Jäger, L. 1980: Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration Acta Biologica et Medica Germanica 39(2-3): 223-227
Klausch, B.; Straube, W.; Hofmann, R.; Büttner, H.H.; Jenssen, H.L.; Köhler, H.; Günther, J. 1977: The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report Annales Chirurgiae et Gynaecologiae 66(4): 209-213
Nĕmecková, S.; Bubeník, J.; Indrová, M. 1982: Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test Folia Biologica 28(4): 280-282
Ristau, E.; Schlott, B.; Gryschek, G.; Wittmann, W. 1982: Differences of the in vitro reactivity of lymphocytes from normal and persistently lymphocytotic cows to enzootic bovine leukosis tumour membrane extracts as detected with the macrophage-electrophoretic mobility test Acta Biologica et Medica Germanica 41(7-8): 705-713
Miuller, M.; Irmsher, I.; Fisher, R.; Grosmann, G. 1976: Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas Voprosy Onkologii 22(12): 43-50
Lasson, U.; Scherer, G.; Müller-Ruchholtz, W. 1981: Evidence that electrophoretic-mobility (EM) test is of no value for the diagnosis of cancer in children Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 129(3): 164-167
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Matiushichev, V.B.; Shamratova, V.G.; Akhunova, A.R. 1997: Correlation between electrophoretic mobility of human blood erythrocytes and hemoglobin level in health and in renal pathology Fiziologiia Cheloveka 23(4): 110-112
Carnegie, P.R.; Caspary, E.A.; Dickinson, J.P.; Field, E.J. 1973: The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. a study of the kinetics Clinical and Experimental Immunology 14(1): 37-45
Light, P.A.; Preece, A.W.; Waldron, H.A. 1975: Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease Clinical and Experimental Immunology 22(2): 279-284
Jessen, P.; Nielsen, B.; Jensen, I.M.; Ellegaard, J.; Hokland, P. 1992: Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation Ugeskrift for Laeger 154(52): 3754-3757
Kusama, M.; Utsunomiya, Y.; Ono, T.; Nagura, H.; Enomoto, S. 1983: Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1796-1802
Ricci, C.; Minetto, E.; Cascio, G.; De Stefano, A.; Basso, M.; Borelli, P.; Bozzone, D.; Delia, D.; Baldassi, R. 1984: Normalization of electrophoretic mobility of lymphocytes in patients with primary immunoglobulin deficiency treated with intravenous immunoglobulins Acta Medica Hungarica 41(4): 297-302
Pulay, T.; Keller, G.; Krommer, K.; Kovács, C. 1973: Immunoglobulin level in malignant gynecologic diseases and tumor patients Orvosi Hetilap 114(52): 3146-3148
Gil'mutdinov, R.I.; Sergeev, V.A.; Valimukhametova, D.A. 1993: Erythrocyte electrophoretic mobility and other blood rheological indices in patients with acute pneumonia and chronic bronchitis before and after treatment Gematologiia i Transfuziologiia 38(3): 42-43
Kovarík, J.; Lauerová, L.; Ninger, E.; Munzarová, M.; Feit, J.; Zemanová, D.; Wotke, R. 1983: Evaluation of the LAi test in patients with benign and malignant breast diseases Neoplasma 30(2): 163-167
Gutman, H.; Kott, I.; Rabinerson, D.; Reiss, R. 1986: Macrophage migration inhibition factor test in breast tumors Israel Journal of Medical Sciences 22(11): 812-816